We are live on ! Find out more
JAGX icon

Jaguar Health
JAGX

6 hedge funds and large institutions have $367K invested in Jaguar Health in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more ownership

Funds ownership: 0% → 0% (+0%)

30% less capital invested

Capital invested by funds: $524K → $367K (-$157K)

57% less funds holding

Funds holding: 14 → 6 (-8)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
6
Holders Change
-8
Holders Change %
-57.14%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$238K
2
PCM
Perritt Capital Management
Illinois
+$205K
3
Squarepoint
Squarepoint
New York
+$185K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$59.6K
5
TRCT
Tower Research Capital (TRC)
New York
+$13.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$358K
2
Jane Street
Jane Street
New York
-$71.8K
3
XT
XTX Topco
Cayman Islands
-$40.5K
4
Bank of America
Bank of America
North Carolina
-$33.1K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$33.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$110K +$238K +36 +1,200%
PCM
2
Perritt Capital Management
Illinois
$89.5K +$205K +31 New
Squarepoint
3
Squarepoint
New York
$80.9K +$185K +28 New
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$39K -$33.1K -5 -26%
Vanguard Group
5
Vanguard Group
Pennsylvania
$37.1K +$59.6K +9 +225%
TRCT
6
Tower Research Capital (TRC)
New York
$8.6K +$13.2K +2 +200%
Morgan Stanley
7
Morgan Stanley
New York
$902 – – –
BlackRock
8
BlackRock
New York
$394 -$358K -54 Closed
Bank of America
9
Bank of America
North Carolina
$143 -$33.1K -5 Closed
Group One Trading
10
Group One Trading
Illinois
$36 – – –
IAIM
11
International Assets Investment Management
Florida
$7 – – –
CA
12
CoreCap Advisors
Michigan
$4 – – –
Jane Street
13
Jane Street
New York
– -$71.8K -17 Closed
XT
14
XTX Topco
Cayman Islands
– -$40.5K -9 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$14.1K -3 Closed
CAG
16
Csenge Advisory Group
Florida
– -$9.21K -2 Closed
FWM
17
Focused Wealth Management
New York
– -$6.66K -2 Closed
BFM
18
Boothbay Fund Management
New York
– -$4.47K -1 Closed
Two Sigma Investments
19
Two Sigma Investments
New York
– -$2.34K -1 Closed
UBS Group
20
UBS Group
Switzerland
– -$3.92K -1 Closed
IGWM
21
ICA Group Wealth Management
Colorado
– -$405 – –
Wells Fargo
22
Wells Fargo
California
– -$34 – –

JAGX Hedge Fund Activity: Q2 2024 in Review

6 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q2 2024, worth a combined $367K — down 30% from $524K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of JAGX and 2 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was Geode Capital Management, adding an estimated $238K. The largest seller was BlackRock, exiting entirely with an estimated $358K sold.

  • 6 institutional investors held Jaguar Health (JAGX) as of Q2 2024, down from 14 in Q1 2024.
  • Funds reported $367K of Jaguar Health stock for Q2 2024, down 30% quarter-over-quarter.
  • 2 funds opened new Jaguar Health positions in Q2 2024 and 10 closed out, a net change of -8 holders.
  • The largest Jaguar Health buyer in Q2 2024 was Geode Capital Management, an estimated $238K added.
  • The largest Jaguar Health seller in Q2 2024 was BlackRock, an estimated $358K sold.

Based on aggregated 13F filings for Q2 2024.